Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 9,735 | 15,559 |
| Marketable Securities | 0 | 0 | 254 | 546 |
| Other current assets | 0 | 0 | 379 | 386 |
| TOTAL | $0 | $0 | $10,368 | $16,491 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 13 | 14 |
| TOTAL | $N/A | $N/A | $13 | $14 |
| Total Assets | $0 | $0 | $10,536 | $16,757 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,035 | 259 |
| Accrued Expenses | 0 | 0 | 235 | 236 |
| TOTAL | $0 | $0 | $1,382 | $595 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 2 | 19 |
| TOTAL | $N/A | $N/A | $2 | $19 |
| Total Liabilities | $0 | $0 | $1,434 | $776 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | -37,739 | -30,531 |
| Other shareholders' equity | 0 | 0 | 43,904 | 43,904 |
| TOTAL | $0 | $0 | $9,102 | $15,981 |
| Total Liabilities And Equity | $0 | $0 | $10,536 | $16,757 |